A Phase 3, Open-Label Period Followed by a Randomized, Double-blind Placebo-controlled Study of the Analgesic Efficacy of Extended-release Hydrocodone/Acetaminophen (Vicodin CR) Compared to Placebo in Subjects With Chronic Low Back Pain

Trial Profile

A Phase 3, Open-Label Period Followed by a Randomized, Double-blind Placebo-controlled Study of the Analgesic Efficacy of Extended-release Hydrocodone/Acetaminophen (Vicodin CR) Compared to Placebo in Subjects With Chronic Low Back Pain

Completed
Phase of Trial: Phase III

Latest Information Update: 26 Dec 2013

At a glance

  • Drugs Hydrocodone/paracetamol (Primary)
  • Indications Back pain
  • Focus Registrational; Therapeutic Use
  • Sponsors Abbott Laboratories
  • Most Recent Events

    • 03 Jan 2013 Actual end date change from Apr 2009 to Mar 2009 as reported by ClinicalTrials.gov.
    • 03 Jan 2013 Actual initiation date changed from Aug 2008 to Sep 2008 as reported by ClinicalTrials.gov.
    • 15 May 2009 Planned number of patients changed from 200 to 223 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top